Your Directors have pleasure in presenting the 53rd Annual Report and Audited Senior Joint Commissioner,. Kolkata. Delhi Value Added Tax. Ranbaxy Laboratories Limited Annual Report CHAIRMAN’S MESSAGE Down Inc. Germany (upto 16 December ) 11 Ranbaxy Unichem Co. Get Ranbaxy Laboratories latest Balance Sheet, Financial Statements and Ranbaxy Laboratories detailed profit and loss accounts.

Author: Grogami Bajind
Country: Slovenia
Language: English (Spanish)
Genre: Health and Food
Published (Last): 25 July 2009
Pages: 243
PDF File Size: 4.69 Mb
ePub File Size: 11.92 Mb
ISBN: 978-4-54932-953-8
Downloads: 69523
Price: Free* [*Free Regsitration Required]
Uploader: Akinozil

Nifty pares losses; Ranbaxy,Cipla lead 25 Sep 09 Quick Links for ranbaxylaboratories. ESOS provides that the grant price of options will be the latest available closing price on the stock exchange on which the shares of the Company are listed, prior to the date of the meeting of the Committee in which the options are granted. As at 31 Marchthere are no such derivative contracts which are classifed as cash fow hedges. In calculating these provisions, the management has used the best information and estimates, presently available.

The Company has not accepted the same and has fled its objections before the DRP. The same is expected to be resumed shortly. The ineffectiveness arising from cash fow hedges which was recognised in Statement of Proft and Loss was not material.

This scheme limits the maximum grant of options to an employee or a director at 30, in any given year. Your Account is not yet activated Click here to receive activation mail once again.

Thank you for your kind understanding.

The amount above represents the difference payable. Commitments i Estimated amount of contracts remaining to be executed on capital account and not Dion Global Solutions Limited.

The Company is fully cooperating with this information request and is in dialogue with the US Repogt for submission of the requisite information. Since the matter involves signifcant judgement and in view of the inherent uncertainty of the present situation, the actual amounts may differ eventually.

  LM239D DATASHEET PDF

Annual Reports

Please do reach out to us at contactus reportjunction. Consequently, stock write off and other costs of Rs.

Pf party disclosures A] Names of related parties Related parties where control exists with whom no transactions have taken place during the current period or previous year: ESOS I and II provide that the grant price of options is to be determined at the average of the daily closing price of the Company”s equity shares on the NSE during a period of 26 weeks preceding the date of the grant.

The effective portion of such cash fow hedges was recorded as part of reserves and surplus within hedging reserve and re-classifed in the Statement of Proft and Loss in the period corresponding to the occurrence of the highly probable forecasted transactions.

Ranbaxy UK Limited, U. Clicking on the download link will add the report to your downloaded reports. Ranbaxy Laboratories is not traded in the last 30 days.

Nifty bounces over ; Bharti languishes 17 Feb 10 However, considering the above matters relating to the Toansa manufacturing facility, provisions primarily relating to inventories, trade commitments, sales return etc. The Company received the fnal assessment order from the AO in November whereby demand of Rs The amount is excluding interest and penalty, if any. Foreign funds hint at hiking India allocation 25 Mar 10 Segment information In accordance with AS 17, Segment Reporting, segment information has been given in the consolidated fnancial statements of the Company, and therefore, no separate disclosure on segment information is given in these fnancial statements.

Daiichi Sankyo Propharma Co. Pursuant to the transaction, the Company has recorded a gain of Rs.

Annual Reports & Presentations

Company overview Ranbaxy Laboratories Limited ”the Company” together with its subsidiaries and associates, operates as an integrated international pharmaceutical organisation with businesses encompassing the entire value chain in the marketing, production and distribution of pharmaceutical products. Consequent to the fndings of the above exercise, the carrying amount of inventory has been written down by Rs. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.

  1N9148 DATASHEET PDF

Hence, the Company has become a potentially sick company in ranbaxyy of the provisions of Sick Industrial Companies Special Provisions Act, and requisite compliances under this Act would be made by the Company.

Annual Reports & Presentations | Sun Pharmaceutical Industries Ltd.

Due to the nature of these disputes and also in view of signifcant uncertainty of outcome, the Company believes that the amount of exposure cannot be currently determinable. It is the largest exporter of bulk drugs and pharmaceutical dosag.

A, Italy Ranbaxy Malaysia Sdn. Contingent liabilities and commitments to the extent not provided for As at As at 31 March 31 December Contingent liabilities i Guarantees a Letter of comfort on behalf of subsidiaries, to the extent of limits 6, 2010-111 Company expects to resume the operations shortly.

Options are granted at the discretion of the committee to selected employees depending upon certain criterion. The Company will issue shares to the Trust which will allocate the shares to the respective employees upon exercise of stock options from time to time under ESOP – Free reports will not be deducted from your subscription.

Ranbaxy gets approval from Japan for Dewas unit; stk up 24 Jul 09 Options lapse, if they are not exercised prior to the expiry date, which is three months from the date of the vesting. It also includes a demand of Annuzl. The options vests evenly over a period of fve years from the date of grant.